remission

New ‘Chemoimmunotherapy’ Proves Potent Against Prostate Cancers

In spite of aggressive chemotherapy treatments, advanced prostate cancers have proven to be quite difficult to treat. As a heterogeneous mass of different cancerous mutations, prostate tumors often evade cellular death, and have even been known to accumulate cells capable of suppressing a body’s immunological defenses. But in a new study published this week in the journal Nature, researchers have found that chemotherapy, when paired with immunotherapy, is a potent duo that has already proven successful in achieving prostate cancer remission in mouse models—now they think that the strategy may be ready to treat humans.

Recommended Stories

Real Time Analytics